SYN-TECH Chem. & Pharm. Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	684.43	656.8	666.92	844.96	1,230	619.15
Short-Term Investments	-	-	-	-	27	-
Cash & Short-Term Investments	684.43	656.8	666.92	844.96	1,257	619.15
Cash Growth	6.67%	-1.52%	-21.07%	-32.77%	103.00%	27.04%
Accounts Receivable	190.2	156.44	142.08	120.56	91.77	92.03
Other Receivables	0.8	2.15	140.75	145.36	221.37	1.73
Receivables	191	158.59	282.84	265.92	313.13	93.75
Inventory	351.44	503.31	459.98	353.63	322.13	294.44
Prepaid Expenses	27.32	14.62	10.5	10.84	11.25	12.83
Other Current Assets	-	-	-	119.16	232.09	-
Total Current Assets	1,254	1,333	1,420	1,595	2,135	1,020
Property, Plant & Equipment	1,413	1,489	1,452	1,069	668.88	723.09
Long-Term Investments	7.73	7.73	9.72	8.53	25.25	26.62
Other Intangible Assets	0.04	0.06	0.08	0.21	0.4	0.28
Long-Term Deferred Tax Assets	5.93	6.32	12	7.95	7.66	8.87
Other Long-Term Assets	19.19	14.96	7.27	99.3	57.42	2.99
Total Assets	2,700	2,852	2,901	2,779	2,895	1,782
Accounts Payable	45.13	52.94	87.6	113.72	67.86	39.67
Accrued Expenses	-	83.82	-	-	-	-
Short-Term Debt	-	-	260	250	647.48	280
Current Portion of Leases	3.15	3.11	3.07	3.03	2.3	2.05
Current Income Taxes Payable	1.47	54.37	63.85	60.91	24.48	47.65
Current Unearned Revenue	1.87	4.75	0.03	0.02	1.45	0.02
Other Current Liabilities	85.73	20.48	92.47	76.06	96.41	93.39
Total Current Liabilities	137.34	219.47	507.01	503.73	839.98	462.78
Long-Term Leases	55.18	57.54	60.65	63.72	51.03	53.33
Pension & Post-Retirement Benefits	-	-	-	-	7.44	11.95
Long-Term Deferred Tax Liabilities	14.31	14.64	12.68	12.67	13.25	13.4
Other Long-Term Liabilities	-	-	3.14	-	-	-
Total Liabilities	206.83	291.65	583.48	580.13	911.71	541.46
Common Stock	445.92	445.92	445.92	445.92	400.6	300.6
Additional Paid-In Capital	983.78	983.78	983.78	983.78	822.23	314.35
Retained Earnings	1,067	1,134	891.54	773.91	614.57	630.29
Comprehensive Income & Other	-3.3	-3.3	-3.82	-4.3	145.95	-4.68
Shareholders' Equity	2,494	2,560	2,317	2,199	1,983	1,241
Total Liabilities & Equity	2,700	2,852	2,901	2,779	2,895	1,782
Total Debt	58.32	60.65	323.72	316.75	700.81	335.38
Net Cash (Debt)	626.11	596.15	343.2	528.21	556.05	283.77
Net Cash Growth	7.91%	73.70%	-35.03%	-5.00%	95.95%	-
Net Cash Per Share	14.00	13.34	7.68	11.83	15.76	9.42
Filing Date Shares Outstanding	44.59	44.59	44.59	44.59	40.06	30.06
Total Common Shares Outstanding	44.59	44.59	44.59	44.59	40.06	30.06
Working Capital	1,117	1,114	913.22	1,091	1,295	557.39
Book Value Per Share	55.92	57.41	51.97	49.32	49.51	41.27
Tangible Book Value	2,494	2,560	2,317	2,199	1,983	1,240
Tangible Book Value Per Share	55.92	57.41	51.97	49.32	49.50	41.26
Land	206.79	203.97	75.97	75.97	75.97	75.97
Buildings	464.22	456.39	281.95	197.71	198.76	185.08
Machinery	1,395	1,366	1,321	860.82	651.87	669.93
Construction In Progress	0.43	5.95	193.19	258.36	33.71	81.92

Source: S&P Global Market Intelligence. Standard template. Financial Sources.